Vertex Pharmaceuticals, Inc. (VRTX)
558.88
+18.88
(+3.50%)
USD |
NASDAQ |
Oct 30, 16:00
558.00
-0.88
(-0.16%)
After-Hours: 20:00
Vertex Pharmaceuticals 30-Day Average Daily Volume : 1.263M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.263M |
| October 29, 2026 | 1.243M |
| October 28, 2026 | 1.222M |
| October 27, 2026 | 1.200M |
| October 26, 2026 | 1.194M |
| October 23, 2026 | 1.182M |
| October 22, 2026 | 1.183M |
| October 21, 2026 | 1.156M |
| October 20, 2026 | 1.140M |
| October 19, 2026 | 1.136M |
| October 16, 2026 | 1.119M |
| October 15, 2026 | 1.099M |
| October 14, 2026 | 1.081M |
| October 13, 2026 | 1.036M |
| October 12, 2026 | 1.037M |
| October 09, 2026 | 1.034M |
| October 08, 2026 | 1.013M |
| October 07, 2026 | 991353.6 |
| October 06, 2026 | 990293.5 |
| October 05, 2026 | 990040.9 |
| October 02, 2026 | 995369.4 |
| October 01, 2026 | 999463.0 |
| September 30, 2026 | 1.008M |
| September 29, 2026 | 1.019M |
| September 28, 2026 | 1.033M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.044M |
| September 24, 2026 | 1.047M |
| September 23, 2026 | 1.051M |
| September 22, 2026 | 1.046M |
| September 21, 2026 | 1.089M |
| September 18, 2026 | 1.092M |
| September 17, 2026 | 1.044M |
| September 16, 2026 | 1.061M |
| September 15, 2026 | 1.107M |
| September 14, 2026 | 1.130M |
| September 11, 2026 | 1.134M |
| September 10, 2026 | 1.146M |
| September 09, 2026 | 1.167M |
| September 08, 2026 | 1.192M |
| September 04, 2026 | 1.209M |
| September 03, 2026 | 1.224M |
| September 02, 2026 | 1.241M |
| September 01, 2026 | 1.226M |
| August 31, 2026 | 1.238M |
| August 28, 2026 | 1.235M |
| August 27, 2026 | 1.258M |
| August 26, 2026 | 1.276M |
| August 25, 2026 | 1.287M |
| August 24, 2026 | 1.298M |
| August 21, 2026 | 1.311M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.928M |
| Sionna Therapeutics, Inc. | 1.123M |
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| Regeneron Pharmaceuticals, Inc. | 753586.4 |
| Amgen, Inc. | 2.742M |